Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Share-based Compensation (2016 - 2025)

KalVista Pharmaceuticals' Share-based Compensation history spans 10 years, with the latest figure at $3.6 million for Q2 2025.

  • On a quarterly basis, Share-based Compensation rose 65.55% to $3.6 million in Q2 2025 year-over-year; TTM through Apr 2025 was $11.9 million, a 4.48% increase, with the full-year FY2025 number at $12.3 million, down 43.92% from a year prior.
  • Share-based Compensation hit $3.6 million in Q2 2025 for KalVista Pharmaceuticals, up from $3.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for KALV hit a ceiling of $3.6 million in Q2 2025 and a floor of $2.2 million in Q2 2024.
  • Historically, Share-based Compensation has averaged $3.0 million across 3 years, with a median of $3.0 million in 2024.
  • Biggest five-year swings in Share-based Compensation: fell 6.58% in 2024 and later soared 65.55% in 2025.
  • Tracing KALV's Share-based Compensation over 3 years: stood at $3.2 million in 2023, then fell by 6.49% to $3.0 million in 2024, then rose by 21.44% to $3.6 million in 2025.
  • Business Quant data shows Share-based Compensation for KALV at $3.6 million in Q2 2025, $3.0 million in Q4 2024, and $3.0 million in Q3 2024.